Ryau1135,

You are throwing around some pretty lofty projections there relative to the company's enterprise value of $325 million USD that Zenith listed in their BIO International presentation a couple of weeks ago. In my opinion, Zenith has not publicly revealed enough information about the status of their mCRPC program or their other clinical/pre-clinical programs to warrant those figures that you posted. Zenith is choosing to keep their cards very close to the chest. All I'm saying is that we have very little public info to go off of to value the company. 

BearDownAZ